Wellbutrin (bupropion) is not approved to treat anxiety, and it can actually cause anxiety as a side effect in some people. That said, the clinical picture is more nuanced than its reputation suggests. When researchers pooled data from 10 clinical trials, bupropion reduced anxiety symptoms in depressed patients almost as effectively as SSRIs, the medications most commonly prescribed for anxiety. The real answer depends on what kind of anxiety you have, whether depression is also in the picture, and how your body responds to the medication.
What Wellbutrin Is Actually Approved For
The FDA has approved Wellbutrin for two conditions: major depressive disorder and prevention of seasonal depressive episodes (seasonal affective disorder). It is not approved for generalized anxiety disorder, social anxiety, panic disorder, or any other anxiety condition. When doctors prescribe it for anxiety, they’re using it off-label, meaning based on their clinical judgment rather than a specific FDA indication.
This matters because the FDA label actually lists anxiety as a known side effect. In clinical trials, about 3% of people taking Wellbutrin reported new or worsening anxiety, compared to 1% on placebo. Agitation was even more common, affecting roughly 32% of patients versus 22% on placebo. Tremor showed up in about 21% of patients. These numbers come from the immediate-release formulation, and rates tend to be lower with the extended-release (XL) version that most people take today.
How It Works Differently Than SSRIs
Most anxiety medications, including SSRIs like sertraline and escitalopram, work by increasing serotonin activity in the brain. Wellbutrin takes a completely different approach. It blocks the reabsorption of two other brain chemicals: norepinephrine and dopamine. It doesn’t directly affect serotonin at all, which makes it unique among antidepressants.
Norepinephrine is closely tied to your body’s alertness and stress response. Boosting it can improve energy, focus, and motivation, which is why Wellbutrin tends to feel more activating than SSRIs. But that same activating quality is also why some people feel more keyed up or jittery on it, especially in the first few weeks. For someone whose anxiety already involves a lot of physical restlessness or racing thoughts, this activation can feel like the medication is making things worse.
What the Research Says About Anxiety Relief
Despite its reputation for worsening anxiety, the clinical data tells a more balanced story. A meta-analysis of 10 randomized trials compared bupropion head-to-head with SSRIs in patients who had both depression and anxiety symptoms. Both groups saw nearly identical reductions in anxiety scores. The average improvement on a standard anxiety scale was 8.8 points with bupropion versus 9.1 points with an SSRI, a difference that wasn’t statistically meaningful. Among patients whose depression fully remitted, about 9.5% on bupropion still had significant residual anxiety compared to 8.4% on an SSRI. Again, no real difference.
Where SSRIs did show a slight edge was in patients specifically classified as having “anxious depression,” a subtype where anxiety symptoms are particularly prominent alongside the depressive episode. In that group, the anxiety response rate was 54.5% for bupropion versus 61.5% for SSRIs. That gap was statistically significant but clinically tiny. The average SSRI patient scored less than one point better on the depression rating scale than the average bupropion patient. Remission rates for both anxiety and depression were the same between the two drugs.
The researchers’ conclusion was blunt: contrary to what many clinicians assume, bupropion and SSRIs appear roughly equivalent for treating anxiety symptoms in the context of depression.
Where Wellbutrin Falls Short for Anxiety
That equivalence comes with an important caveat. Nearly all the research on bupropion and anxiety has been done in people who had depression as their primary diagnosis, with anxiety tagging along. If your main problem is an anxiety disorder without significant depression, the evidence supporting Wellbutrin is much thinner. There are no large randomized trials showing it works for generalized anxiety disorder, social anxiety disorder, or obsessive-compulsive disorder on its own.
There is limited case-level evidence for panic disorder. One published case followed a patient treated with bupropion over 72 weeks who saw improvement in panic symptoms over the first 12 to 24 weeks. But a single case report is far from the kind of evidence needed to recommend a medication broadly. For standalone anxiety disorders, SSRIs and SNRIs remain the better-studied first-line options.
Why Some Doctors Still Prescribe It for Anxiety
Wellbutrin often enters the anxiety conversation not as a first choice but as a practical alternative. SSRIs are effective for anxiety, but they come with side effects that drive many people to stop taking them: weight gain, sexual dysfunction, and emotional blunting. Wellbutrin is far less likely to cause any of these. For someone who needs long-term treatment for both depression and anxiety, and who can’t tolerate the side effects of an SSRI, bupropion becomes a reasonable option.
It also gets used as an add-on. In the large STAR*D trial, which tested sequential treatment strategies for depression, adding bupropion to the SSRI citalopram produced higher remission rates in anxious patients than adding buspirone (18% versus 9%). This combination approach lets people get the serotonin-based anxiety relief from the SSRI while using bupropion to counteract side effects like low energy or sexual dysfunction.
What to Expect If You Try It
If you and your prescriber decide to try Wellbutrin for anxiety symptoms, the first few weeks are the most likely period for increased jitteriness or restlessness. Clinicians often recommend starting at a lower dose for people who are anxiety-prone, then increasing gradually. The extended-release (XL) formulation delivers the medication more steadily throughout the day, which generally produces fewer spikes in activation compared to the immediate-release version.
Meaningful improvement in mood and anxiety symptoms typically takes several weeks. In the limited data available, one patient’s panic symptoms improved progressively over 12 to 24 weeks. This is consistent with the general timeline for antidepressants, where early weeks can feel rough before the therapeutic effect builds.
Important Safety Considerations
Wellbutrin lowers the seizure threshold, and the risk increases with higher doses. The maximum recommended dose for the XL formulation is 450 mg per day, though most people take 300 mg or less. Certain conditions make seizures more likely and rule out Wellbutrin entirely: a history of seizure disorder, a current or past diagnosis of anorexia or bulimia, and abrupt withdrawal from alcohol, benzodiazepines, or barbiturates. People with diabetes, those using other medications that lower the seizure threshold, and heavy drinkers also face elevated risk.
The FDA label also flags a broader set of neuropsychiatric effects that have been reported with bupropion, including agitation, panic attacks, irritability, impulsivity, and in rare cases hostility or mania. These events have occurred in both adults and adolescents. If you notice a sharp worsening of anxiety, new panic attacks, or significant behavioral changes after starting the medication, that warrants a prompt conversation with your prescriber about whether to continue.